Medicine News and Research

RSS

Majority of parents continue to give OTC cough and cold medicines to children under 2

Research has linked over-the-counter cough and cold products to poisoning or death in hundreds of children, ages 2 and younger. Studies have also shown that these medicines do little to control symptoms. As a result, in 2008, the United States Food and Drug Administration formally recommended that OTC cough and cold products not be given to children under age 2.

16 Feb 2011

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?

16 Feb 2011

GAVI chair calls for greater reductions in vaccine prices for developing countries

On Monday, the same day the GAVI Alliance helped oversee the roll out of a routine pneumococcal vaccine in Kenya, GAVI chairman Dagfinn Hoybraten highlighted the need for greater reductions in vaccine prices in developing countries during an interview with Reuters, the news service reports. The piece examines the funding mechanism in place to finance the pneumococcal vaccines, known as Advance Market Commitment (AMC), as well as the budget shortfall facing the group (Kelland, 2/14).

16 Feb 2011

Study: Expedited medical device reviews account for majority of recalls

The analysis, which was published in the Archives of Internal Medicine, connected the Food and Drug Administration's most urgent medical device recalls with high-risk devices that were subject to "speedy" review.

16 Feb 2011

Halozyme-Roche announce initiation of Phase 3 subcutaneous MabThera trial in follicular NHL

Halozyme Therapeutics, Inc. and Roche today announced the first patient received subcutaneous MabThera (rituximab), an anticancer biologic, in a Phase 3 registration trial using Enhanze technology.

16 Feb 2011

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

Viral Genetics, Inc. announced today that lead researcher Dr. M. Karen Newell Rogers and Advisor Mr. Richard Gerstner will receive the Lauren F. Brooks Hope Award, presented by Time for Lyme, Inc.

16 Feb 2011

Study finds worse outcomes in workers undergoing spinal fusion surgery

For workers' compensation patients with chronic low back pain, spinal fusion surgery leads to worse long-term outcomes—including a lower rate of return to work—compared to nonsurgical treatment, suggests a study in the February 15th issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

16 Feb 2011

BCVI offers multidisciplinary approach to treat patients with atrial fibrillation

More than 2.6 million Americans suffer from atrial fibrillation —an erratic heartbeat. If left untreated, the condition can lead to stroke or heart failure. For three decades, 58 year old David Ryan was one of the millions of Americans suffering from the disease.

16 Feb 2011

Research: Way heart responds to early beat is predictive of cardiac death

The way the heart responds to an early beat is predictive of cardiac death, especially for people with no conventional markers of cardiovascular disease, according to new research from Washington University School of Medicine in St. Louis.

16 Feb 2011

New study: CHG cloths more effective in reducing risk of hospital-acquired infections

A new study from Rhode Island Hospital has found a reduced risk of hospital-acquired infections when using two percent chlorhexidine gluconate cloths for daily bathing instead of soap and water.

16 Feb 2011

Partners, Luminex team up to discover novel biomarkers, develop clinical assays

Luminex Corporation announced today that it has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays.

From Luminex 16 Feb 2011

Orthofix 2010 net sales increase 3% to $564.4 million

Orthofix International N.V. today announced its results for the fourth quarter and year ended December 31, 2010.

16 Feb 2011

AML patient raises awareness in community about national stem cell registry

By the age of 28, Dana Severson was already an Iraq war veteran, an accomplished clinical engineer, a wife and mother. Days following her daughter Genevieve's first birthday, Severson was faced with a reality that would turn her life upside down. After several weeks of experiencing severe headaches and extreme exhaustion, the young mother was diagnosed with acute myeloid leukemia.

16 Feb 2011

Boston Scientific acquires novel technologies for treatment of peripheral chronic total occlusions

Boston Scientific Corporation today announced the acquisition of two novel technologies to treat peripheral chronic total occlusions (CTOs). These acquisitions add technology platforms that complement the Company's world-class portfolio of devices for lower extremity peripheral artery disease.

16 Feb 2011

Bisphosphonates appear to reduce risk of postmenopausal colorectal cancer by 50%

An international team of researchers has found that the use of bisphosphonates - drugs already taken by millions of healthy women to prevent bone-loss - for more than one year was associated with a 50 percent reduction in the risk of postmenopausal colorectal cancer. The results were published this week in the Journal of Clinical Oncology.

15 Feb 2011

Study: Heart rate turbulence is linked with increased risk of death from cardiovascular disease

Abnormal heart rate turbulence is associated with an increased risk of heart disease death in otherwise low-risk older individuals, according to a study funded by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

15 Feb 2011

NTI awards $295,172 to BMC chief for acute lung injury study

Suresh Agarwal, MD, the chief of surgical critical care at Boston Medical Center and an associate professor of medicine at Boston University School of Medicine, has received a $295,172 grant from the National Trauma Institute to identify optimal treatment methods for acute lung injury.

15 Feb 2011

The Lancet publishes Baxter's PREFLUCEL phase III trial results against seasonal influenza

Baxter International Inc. announced today results of a study published in this week's issue of The Lancet that demonstrate effectiveness and tolerability of Baxter's PREFLUCEL in protecting against seasonal influenza.

From Baxter International Inc. 15 Feb 2011

RPCI offers first FDA-approved cancer treatment vaccine

The nation's first FDA-approved cancer treatment vaccine, Provenge, is being offered for the first time in Western New York at Roswell Park Cancer Institute.

15 Feb 2011

Efficacy of zinc in common cold - Review of clinical trials

A new study has added to the existing literature that debates the role of zinc in combating the common cold. It suggests that the supplement might modestly reduce cold duration and severity or maybe even prevent it. The report was published as a Cochrane Review.

15 Feb 2011

Medicine News and Research

Majority of parents continue to give OTC cough and cold medicines to children under 2

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

GAVI chair calls for greater reductions in vaccine prices for developing countries

Study: Expedited medical device reviews account for majority of recalls

Halozyme-Roche announce initiation of Phase 3 subcutaneous MabThera trial in follicular NHL

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

Study finds worse outcomes in workers undergoing spinal fusion surgery

BCVI offers multidisciplinary approach to treat patients with atrial fibrillation

Research: Way heart responds to early beat is predictive of cardiac death

New study: CHG cloths more effective in reducing risk of hospital-acquired infections

Partners, Luminex team up to discover novel biomarkers, develop clinical assays

Orthofix 2010 net sales increase 3% to $564.4 million

AML patient raises awareness in community about national stem cell registry

Boston Scientific acquires novel technologies for treatment of peripheral chronic total occlusions

Bisphosphonates appear to reduce risk of postmenopausal colorectal cancer by 50%

Study: Heart rate turbulence is linked with increased risk of death from cardiovascular disease

NTI awards $295,172 to BMC chief for acute lung injury study

The Lancet publishes Baxter's PREFLUCEL phase III trial results against seasonal influenza

RPCI offers first FDA-approved cancer treatment vaccine

Efficacy of zinc in common cold - Review of clinical trials

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News